2. V Khullar et al. Efficacy and tolerability of mirabegron, a β(3)-adrenoreceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial. Eur Urol 2013; 63:283.
4. H Otsuki et al. β3-adrenoceptor agonist mirabegron is effective for overactive bladder that is unresponsive to antimuscarinic treatment or is related to benign prostatic hyperplasia in men. Int Urol Nephrol 2013; 45:53.